ARTICLE | Clinical News
Tocagen preclinical data
February 13, 2012 8:00 AM UTC
In a mouse model of glioblastoma, Toca 511 followed by 5-flucytosine (5-FC) eradicated brain tumors and increased survival to >180 days vs. 43 days for mice receiving a control vector. Tocagen said To...